SCHEMBL4820865

SCHEMBL4820865

CC(Nc1c(-c2ccc(F)cc2)c(Cl)nc2ncnn12)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 1/20 0.35
MAPK14 Q16539 5/20 0.35
MAPK1 P28482 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
APP P05067 1/20 0.32
PLK1 P53350 1/20 0.32
MBOAT4 Q96T53 1/20 0.32
EGLN2 Q96KS0 1/20 0.32
MAPK13 O15264 2/20 0.32
MAPK12 P53778 2/20 0.32
MAPK11 Q15759 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7492723 0.86 ALDH1A1 (0.35) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL4821067 0.85 ALDH1A1 (0.32) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL80486 0.84 MAPK1 (0.35) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL3117730 0.84 MAPK1 (0.35) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL977522 0.84 MAPK1 (0.35) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL4819838 0.82 ALDH1A1 (0.34) ALDH1A1GAAMEN1KMT2ALMNA
SCHEMBL4820336 0.81 ALDH1A1 (0.33) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL25616307 0.81 ALDH1A1 (0.35) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL5232228 0.81 KDM4E (0.42) KDM4EALDH1A1HPGDMAPK1LMNA
SCHEMBL23925473 0.81 ALDH1A1 (0.33) ALDH1A1GAAMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329663-B2 Substituted-triazolopyrimidines as anticancer agents WYETH (US) 2008-02-12 US claimed
US-20020068744-A1 Substituted-triazolopyrimidines as anticancer agents AMERICAN HOME PRODUCTS CORPORATION 2002-06-06 US claimed
US-7329663-B2 Substituted-triazolopyrimidines as anticancer agents WYETH (US) 2008-02-12 US disclosed
US-20020068744-A1 Substituted-triazolopyrimidines as anticancer agents AMERICAN HOME PRODUCTS CORPORATION 2002-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020068744-A1 Substituted-triazolopyrimidines as anticancer agents TUBB3, TUBA1C, TUBB1 KDM4E 3074/4885ALDH1A1 2231/4885GAA 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.